查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878987

冷療疼痛治療市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、應用、配銷通路、地區和競爭格局分類，2020-2030年預測

Cold Pain Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product, By Application, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球冷療疼痛市場規模為22.8億美元，預計2030年將以5.72%的複合年成長率成長至31.8億美元。冷療疼痛，也稱為冷凍療法，是指透過局部應用冷療來緩解疼痛、減輕發炎和消腫。推動市場成長的主要因素包括全球老齡人口的成長，這導致與年齡相關的肌肉骨骼疾病盛行率上升，以及運動傷害和創傷事故發生率的增加。此外，患者越來越傾向於選擇非藥物、非侵入性的疼痛管理方案，而非鴉片類藥物，這也顯著促進了市場成長。

市場概覽
預測期 2026-2030
2024年市場規模 22.8億美元
2030年市場規模 31.8億美元
2025-2030年複合年成長率 5.72%
成長最快的細分市場 非處方藥
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球冷療疼痛市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（非處方藥、處方藥）
    • 依應用領域（肌肉骨骼疾病、術後復健、運動傷害、其他）
    • 按配銷通路（零售藥局、醫院藥局、網路藥局）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美冷療疼痛市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲冷療疼痛市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區冷療疼痛市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲冷療疼痛市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲冷療疼痛市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球冷療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Hisamitsu Pharmaceutical CO., Inc
  • 3M Company
  • Johnson & Johnson Service Inc.
  • Pfizer Inc.
  • DeRoyal Industries, Inc.
  • Sanofi SA
  • Beiersdorf AG
  • Ossur hf.
  • Cardinal Health Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14576

The Global Cold Pain Therapy Market, valued at USD 2.28 Billion in 2024, is projected to experience a CAGR of 5.72% to reach USD 3.18 Billion by 2030. Cold pain therapy, also known as cryotherapy, involves the localized application of cold to alleviate pain, reduce inflammation, and minimize swelling. Key market drivers include the rising global geriatric population, which increases the prevalence of age-related musculoskeletal conditions, alongside a growing incidence of sports injuries and traumatic accidents. Furthermore, escalating patient preference for non-pharmacological, non-invasive pain management solutions over opioid-based alternatives significantly supports market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.28 Billion
Market Size 2030USD 3.18 Billion
CAGR 2025-20305.72%
Fastest Growing SegmentOTC Products
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of musculoskeletal disorders significantly drives the global cold pain therapy market. Conditions such as chronic back pain and osteoarthritis frequently necessitate effective pain and inflammation management. According to the Centers for Disease Control and Prevention NCHS Data Brief, in October 2024, 24.3% of U. S. adults reported experiencing chronic pain in 2023, a substantial portion of which benefits from non-pharmacological cold therapy interventions. Concurrently, the rising incidence of sports and traumatic injuries acts as another critical market accelerant. Individuals facing accidental trauma or sports-related injuries often require immediate and ongoing cold therapy for swelling reduction, pain alleviation, and accelerated recovery.

Key Market Challenges

A primary challenge impeding the expansion of the Global Cold Pain Therapy Market is the pervasive availability and widespread use of low-cost alternative pain relief options, specifically oral analgesic pills. Consumers often favor oral analgesics due to their convenience, immediate accessibility in diverse retail environments, and significantly lower unit cost compared to cold therapy devices or recurring cold pack purchases. This ingrained preference for familiar, inexpensive pharmaceutical solutions for various types of pain creates a formidable barrier to the broader adoption of cold therapy.

This strong consumer reliance on readily available and economical oral medications directly hinders market penetration for cold pain therapy. While cold therapy offers distinct non-pharmacological benefits, the established habit of choosing pills for quick symptomatic relief presents a substantial competitive disadvantage. According to the Consumer Healthcare Products Association, in 2023, retail sales of all over-the-counter medicines in the US reached $43.4 billion, demonstrating the considerable scale and entrenched consumer dependency on these accessible pharmaceutical alternatives. This vast and cost-effective market for oral analgesics limits growth opportunities and shifts potential customers away from cold pain therapy solutions.

Key Market Trends

The integration of smart technology significantly enhances cold pain therapy through improved functionality and personalized treatment. Devices now feature app connectivity, remote monitoring, and intelligent controls for precise temperature regulation. This supports real-time progress tracking and better recovery management. According to the U. S. Department of Health and Human Services, IoT-enabled healthcare devices increased by 45% between 2021 and 2023, showcasing a broad industry shift towards connected health. At CES 2024, Infuzamed introduced a wearable infusion pump with advanced remote monitoring, demonstrating potential for similar integration in cold therapy for continuous, personalized care.

Key Market Players

  • Hisamitsu Pharmaceutical CO., Inc
  • 3M Company
  • Johnson & Johnson Service Inc.
  • Pfizer Inc.
  • DeRoyal Industries, Inc.
  • Sanofi SA
  • Beiersdorf AG
  • Ossur hf.
  • Cardinal Health Inc.

Report Scope:

In this report, the Global Cold Pain Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cold Pain Therapy Market, By Product:

  • OTC Products
  • Prescription Products

Cold Pain Therapy Market, By Application:

  • Musculoskeletal Disorders
  • Post-Operative Therapy
  • Sport Injuries
  • Others

Cold Pain Therapy Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Cold Pain Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cold Pain Therapy Market.

Available Customizations:

Global Cold Pain Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cold Pain Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (OTC Products, Prescription Products)
    • 5.2.2. By Application (Musculoskeletal Disorders, Post-Operative Therapy, Sport Injuries, Others)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Cold Pain Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cold Pain Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Cold Pain Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Cold Pain Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Distribution Channel

7. Europe Cold Pain Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cold Pain Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Cold Pain Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Cold Pain Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Cold Pain Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Cold Pain Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Cold Pain Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cold Pain Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Cold Pain Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Cold Pain Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Cold Pain Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Cold Pain Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Cold Pain Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cold Pain Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Cold Pain Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Cold Pain Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Distribution Channel

10. South America Cold Pain Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cold Pain Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Cold Pain Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Cold Pain Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cold Pain Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hisamitsu Pharmaceutical CO., Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. 3M Company
  • 15.3. Johnson & Johnson Service Inc.
  • 15.4. Pfizer Inc.
  • 15.5. DeRoyal Industries, Inc.
  • 15.6. Sanofi SA
  • 15.7. Beiersdorf AG
  • 15.8. Ossur hf.
  • 15.9. Cardinal Health Inc.

16. Strategic Recommendations

17. About Us & Disclaimer